236 related articles for article (PubMed ID: 36898085)
1. Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma.
Carbone A; Gloghini A; Carlo-Stella C
Blood; 2023 May; 141(18):2187-2193. PubMed ID: 36898085
[TBL] [Abstract][Full Text] [Related]
2. PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas.
Xie W; Medeiros LJ; Li S; Yin CC; Khoury JD; Xu J
Curr Hematol Malig Rep; 2020 Aug; 15(4):372-381. PubMed ID: 32394185
[TBL] [Abstract][Full Text] [Related]
3. Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?
Grant C; Dunleavy K; Eberle FC; Pittaluga S; Wilson WH; Jaffe ES
Curr Hematol Malig Rep; 2011 Sep; 6(3):157-63. PubMed ID: 21590365
[TBL] [Abstract][Full Text] [Related]
4. Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
Gibson SE; Dojcinov S; Dotlic S; Hartmann S; Hsi ED; Klimkowska M; Melle F; Pileri SA; Ramsower CA; Rech K; Rimsza LM; Rodriguez-Pinilla SM; Tousseyn TA; de Jong D; Sabattini E
Virchows Arch; 2023 Dec; 483(6):733-749. PubMed ID: 37530791
[TBL] [Abstract][Full Text] [Related]
5. Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.
Kim HJ; Kim HK; Park G; Min SK; Cha HJ; Lee H; Choi SJ; Na HY; Choe JY; Kim JE
Diagn Pathol; 2019 Dec; 14(1):133. PubMed ID: 31831043
[TBL] [Abstract][Full Text] [Related]
6. Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities.
Tousseyn TA; King RL; Fend F; Feldman AL; Brousset P; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):207-226. PubMed ID: 36274093
[TBL] [Abstract][Full Text] [Related]
7. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
8. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
9. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
[TBL] [Abstract][Full Text] [Related]
10. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
[TBL] [Abstract][Full Text] [Related]
11. Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?
Dunleavy K; Grant C; Eberle FC; Pittaluga S; Jaffe ES; Wilson WH
Curr Hematol Malig Rep; 2012 Sep; 7(3):241-7. PubMed ID: 22833351
[TBL] [Abstract][Full Text] [Related]
12. PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma.
Tobin JWD; Bednarska K; Campbell A; Keane C
Cells; 2021 May; 10(5):. PubMed ID: 34068762
[TBL] [Abstract][Full Text] [Related]
13. Dendritic Cell Markers and PD-L1 are Expressed in Mediastinal Gray Zone Lymphoma.
Pelland K; Mathews S; Kamath A; Cohen P; Hudnall SD; Cotta CV; Xu ML
Appl Immunohistochem Mol Morphol; 2018; 26(10):e101-e106. PubMed ID: 29189264
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma.
Tanaka Y; Maeshima AM; Nomoto J; Makita S; Fukuhara S; Munakata W; Maruyama D; Tobinai K; Kobayashi Y
Eur J Haematol; 2018 May; 100(5):511-517. PubMed ID: 29377256
[TBL] [Abstract][Full Text] [Related]
15. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma without mediastinal disease: mimicking nodular sclerosis classical Hodgkin lymphoma.
Iwaki N; Sato Y; Kurokawa T; Maeda Y; Ohno K; Takeuchi M; Takata K; Orita Y; Nakao S; Yoshino T
Med Mol Morphol; 2013 Sep; 46(3):172-6. PubMed ID: 23512149
[TBL] [Abstract][Full Text] [Related]
16. Immunity reloaded: Deconstruction of the PD-1 axis in B cell lymphomas.
Bednarska K; Nath K; Nicol W; Gandhi MK
Blood Rev; 2021 Nov; 50():100832. PubMed ID: 33896649
[TBL] [Abstract][Full Text] [Related]
17. Optimizing checkpoint inhibitors therapy for relapsed or progressive classic Hodgkin lymphoma by multiplex immunohistochemistry of the tumor microenvironment.
Carbone A; Gloghini A; Pruneri G; Dolcetti R
Cancer Med; 2019 Jun; 8(6):3012-3016. PubMed ID: 31070022
[TBL] [Abstract][Full Text] [Related]
18. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
Savage KJ; Monti S; Kutok JL; Cattoretti G; Neuberg D; De Leval L; Kurtin P; Dal Cin P; Ladd C; Feuerhake F; Aguiar RC; Li S; Salles G; Berger F; Jing W; Pinkus GS; Habermann T; Dalla-Favera R; Harris NL; Aster JC; Golub TR; Shipp MA
Blood; 2003 Dec; 102(12):3871-9. PubMed ID: 12933571
[TBL] [Abstract][Full Text] [Related]
19. [Mediastinal large B-cell lymphoma].
Artemieva AS; Semiglazova TY; Frank GA
Vopr Onkol; 2015; 61(2):280-8. PubMed ID: 26087612
[TBL] [Abstract][Full Text] [Related]
20. [Pathology of the mediastinum. Case 2. B cell unclassifiable lymphoma with intermediate features between classic Hodgkin lymphoma and primary large B cell lymphoma].
Traverse-Glehen A
Ann Pathol; 2015 Jun; 35(3):218-23. PubMed ID: 26001355
[No Abstract] [Full Text] [Related]
[Next] [New Search]